The Remdesivir Ride: What you See is What You Get
...were enrolled and randomly assigned to a treatment group (158 to remdesivir and 79 to placebo).
NIH Funds Phase 1 Safety Study Comparing Use of Remdesivir in Pregnant Women Hospitalized with COVID-19 to Women Not Pregnant
...the USA and around much of the world, remdesivir is heavily used for patients hospitalized with COVID-1…
Remdesivir’s Sordid Regulatory History Calls Efficacy into Question
...It is three times larger than the other three remdesivir studies combined, and “many scientists e…
Gilead Reports on Remdesivir Compassionate Use Program for 53 COVID-19 Patients
...with remdesivir resulted in an improvement in oxygen support class for 68% of patients over a median fo…
University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients
...Professor Yan recommends caution given the “indiscriminate use” of the drug. Extensive Use of Remdes…
Gilead/Remdesivir Update: Politics & Methodology Issues Cloud Research
...remdesivir….” On May 1, the FDA approved emergency use of remdesivir for …
The Global Need for Open and Equitable Access to Remdesivir
...a given that remdesivir will work. Further information is required from ongoing trials, but use of
Remdesivir Use in Multi-National Clinical Trial of Patients with Moderate COVID-19 & Pneumonia: Perplexing Results
...1:1:1 ration in order to receive a 10-day course of remdesivir (n=197), a 5-day course of remde…
Not a ‘Knockout Drug’ But Knocking it Out of the Ballpark: Gilead Windfall as Remdesivir COVID-19 Sales to Hit $1 to $3 billion in 2020
...initiated in May and is schedule to complete in August. Called the ACTT-2 study, it evaluates the combination of ba…
Are Politics & Power Behind the Rise of Remdesivir?
...the “little of no effect” finding came in from WHO. Remdesivir costs $3,120 per five-day co…